Xiaohan Fan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xiaohan Fan has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Bi Huang
State Key Laboratory of Cardiovascular Disease, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College, Beijing, China
4 shared publicationsRutai Hui
State Key Laboratory of Cardiovascular Disease, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College, Beijing, China
4 shared publicationsHaisong Lu
State Key Laboratory of Cardiovascular Disease, Department of Cardiovascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College, Beijing, China
3 shared publications- Yanmin Yang
State Key Laboratory of Cardiovascular Disease, Emergency and Critical Care Centre of Cardiovascular Department, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, People's Republic of China
3 shared publications Zhenhua Zhao
State Key Laboratory of Cardiovascular Disease, Department of Cardiovascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College, Beijing, China
3 shared publicationsJun Zhu
State Key Laboratory of Cardiovascular Disease, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, People's Republic of China
2 shared publications
Latest Publications
- Open Access
Onset seasons and clinical outcomes in patients with Stanford type A acute aortic dissection: an observational retrospective study
Objectives To evaluate the association of onset season with clinical outcome in type A acute aortic dissection (AAD). Design A single-centre, observational retrospective study. Setting The study was conducted in Fuwai Hospital, the National Centre for Cardiovascular Disease, Beijing, China. Participants From 2008 to 2010, a set of consecutive patients with type A AAD, confirmed by CT scanning, were enrolled and divided into four groups according to onset season: winter (December, January and February), spring (March, April and May), summer (June, July and August) and autumn (September, October and November). The primary end points were in-hospital death and all-cause mortality during follow-up. Results Of the 492 cases in this study, 129 occurred in winter (26.2%), 147 in spring (29.9%), 92 in summer (18.7%), and 124 in autumn (25.2%). After a median follow-up of 20.4 months (IQR 9.7–38.9), the in-hospital mortality in cases occurring in autumn was higher than in the other three seasons (23.4% vs 8.4%, pConclusions Onset in autumn may be a factor that increases the risk of in-hospital death from type A AAD, especially in patients who receive conservative treatment. Immediate surgery improves the short-term and long-term outcomes regardless of onset season.
Open AccessOnset seasons and clinical outcomes in patients with Stanford type A acute aortic dissection: an observational retrospective study
Objectives To evaluate the association of onset season with clinical outcome in type A acute aortic dissection (AAD). Design A single-centre, observational retrospective study. Setting The study was conducted in Fuwai Hospital, the National Centre for Cardiovascular Disease, Beijing, China. Participants From 2008 to 2010, a set of consecutive patients with type A AAD, confirmed by CT scanning, were enrolled and divided into four groups according to onset season: winter (December, January and February), spring (March, April and May), summer (June, July and August) and autumn (September, October and November). The primary end points were in-hospital death and all-cause mortality during follow-up. Results Of the 492 cases in this study, 129 occurred in winter (26.2%), 147 in spring (29.9%), 92 in summer (18.7%), and 124 in autumn (25.2%). After a median follow-up of 20.4 months (IQR 9.7–38.9), the in-hospital mortality in cases occurring in autumn was higher than in the other three seasons (23.4% vs 8.4%, pConclusions Onset in autumn may be a factor that increases the risk of in-hospital death from type A AAD, especially in patients who receive conservative treatment. Immediate surgery improves the short-term and long-term outcomes regardless of onset season.
- Open Access
- 1 October 2015
- Published by Wolters Kluwer Health in Medicine
- Vol. 94 (42) , e1761
Impact of Admission White Blood Cell Count on Short- and Long-term Mortality in Patients With Type A Acute Aortic Dissection
Studies have shown inflammation is involved in the development of acute aortic dissection (AAD). The hypothesis that white blood cell count (WBCc) on admission may have an impact on the short- and long-term outcomes of type A AAD was tested in a large-scale, prospective observational cohort study. From 2008 to 2010, a total of 570 consecutive patients with type A AAD in Fuwai hospital were enrolled and were followed up. Baseline characteristics and WBCc on admission were collected. The primary outcomes were 30-day and long-term all-cause mortality. During a median of 1.89 years of follow-up, the 30-day and long-term all-cause mortality were 10.7% and 6.5%, respectively. Univariate Cox regression analysis identified admission WBCc as an independent predictor of 30-day mortality when considered as a continuous variable or as a categorical variable using the cutoff of 11.0 × 109 cells/L (all P < 0.05). After adjustment for age, sex, C-reactive protein, D-dimer, and surgical intervention, elevated admission WBCc (>11.0 × 109 cells/L) remained an independent predictor of 30-day mortality of AAD (hazard ratio = 3.31, 95% confidence interval 1.38–7.93, P = 0.007). No impact of admission WBCc was observed on the long-term all-cause mortality. In conclusion, elevated admission WBCc may be valuable as a predictor of 30-day mortality, and may be useful in the risk stratification of type A AAD during hospitalization.
- 1 October 2015
- Published by Wolters Kluwer Health in Medicine
- Vol. 94 (42) , e1761
Open AccessImpact of Admission White Blood Cell Count on Short- and Long-term Mortality in Patients With Type A Acute Aortic Dissection
Studies have shown inflammation is involved in the development of acute aortic dissection (AAD). The hypothesis that white blood cell count (WBCc) on admission may have an impact on the short- and long-term outcomes of type A AAD was tested in a large-scale, prospective observational cohort study. From 2008 to 2010, a total of 570 consecutive patients with type A AAD in Fuwai hospital were enrolled and were followed up. Baseline characteristics and WBCc on admission were collected. The primary outcomes were 30-day and long-term all-cause mortality. During a median of 1.89 years of follow-up, the 30-day and long-term all-cause mortality were 10.7% and 6.5%, respectively. Univariate Cox regression analysis identified admission WBCc as an independent predictor of 30-day mortality when considered as a continuous variable or as a categorical variable using the cutoff of 11.0 × 109 cells/L (all P < 0.05). After adjustment for age, sex, C-reactive protein, D-dimer, and surgical intervention, elevated admission WBCc (>11.0 × 109 cells/L) remained an independent predictor of 30-day mortality of AAD (hazard ratio = 3.31, 95% confidence interval 1.38–7.93, P = 0.007). No impact of admission WBCc was observed on the long-term all-cause mortality. In conclusion, elevated admission WBCc may be valuable as a predictor of 30-day mortality, and may be useful in the risk stratification of type A AAD during hospitalization.
- 1 June 2015
- Published by Elsevier in The American Journal of Cardiology
- Vol. 115 (11) , 1595-1600
Impact of d-Dimer Levels on Admission on Inhospital and Long-Term Outcome in Patients With Type A Acute Aortic Dissection
- 1 June 2015
- Published by Elsevier in The American Journal of Cardiology
- Vol. 115 (11) , 1595-1600
Impact of d-Dimer Levels on Admission on Inhospital and Long-Term Outcome in Patients With Type A Acute Aortic Dissection
- 1 April 2014
- Published by Elsevier in International Journal of Cardiology
- Vol. 172 (3) , e484-e486
Low admission platelet counts predicts increased risk of in-hospital mortality in patients with type A acute aortic dissection
- 1 April 2014
- Published by Elsevier in International Journal of Cardiology
- Vol. 172 (3) , e484-e486
Low admission platelet counts predicts increased risk of in-hospital mortality in patients with type A acute aortic dissection
- 1 March 2014
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 25 (2) , 161-166
Plasma D-dimer and in-hospital mortality in patients with Stanford type A acute aortic dissection
Plasma D-dimer has been used as a complementary initial diagnostic marker for acute aortic dissection (AAD). However, its prognostic role in patients with Stanford type A AAD has not been clarified. We prospectively enrolled a consecutive series of patients with suspect AAD presented to our emergency department and measured the plasma D-dimer level (Stago-evolution, France) immediately following the admission. The diagnosis of type A AAD was confirmed by aorta angiography with multidetector computed tomography for each patient. Patients were divided into two groups: the deceased group, who died during hospitalization, and the survival group. The predictive value of D-dimer for in-hospital mortality was determined by using univariate and multivariate Cox proportional hazards analyses. A total of 133 patients with Stanford type A AAD were included. During hospitalization, death occurred in 19 (14.3%) patients. The average hospitalization period was 12.2 days. The plasma D-dimer level of the deceased group was significantly higher than that of the survival group (14.7 ± 8.1 vs. 9.0 ± 7.2 μg/ml, P = 0.003). The in-hospital mortality was significantly higher in patients with plasma D-dimer level of at least 20 μg/ml than in those with plasma D-dimer level less than 20 μg/ml (32.3 vs. 7.5%, log rank P < 0.001). In patients not receiving surgical treatment, the in-hospital mortality was significantly higher in patients with plasma D-dimer of at least 20 μg/ml than that in those with plasma D-dimer less than 20 μg/ml (52.4 vs. 16.7%, P = 0.007). After adjustment for age, systolic blood pressure, platelet counts, and intervals from symptom onset to hospital, a high admission D-dimer level (≥20 μg/ml) was still a powerful independent predictor of in-hospital mortality (hazard ratio 3.195, 95% confidence interval 1.110–9.196, P = 0.031). However, the predictive value of high admission D-dimer level disappeared when surgery was added to the Cox multivariate model. Our results suggest a high admission D-dimer level (≥20 μg/ml) might be a powerful predictor for increased in-hospital mortality in patients with Stanford type A AAD, and these patients may benefit more from surgical intervention.
- 1 March 2014
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 25 (2) , 161-166
Plasma D-dimer and in-hospital mortality in patients with Stanford type A acute aortic dissection
Plasma D-dimer has been used as a complementary initial diagnostic marker for acute aortic dissection (AAD). However, its prognostic role in patients with Stanford type A AAD has not been clarified. We prospectively enrolled a consecutive series of patients with suspect AAD presented to our emergency department and measured the plasma D-dimer level (Stago-evolution, France) immediately following the admission. The diagnosis of type A AAD was confirmed by aorta angiography with multidetector computed tomography for each patient. Patients were divided into two groups: the deceased group, who died during hospitalization, and the survival group. The predictive value of D-dimer for in-hospital mortality was determined by using univariate and multivariate Cox proportional hazards analyses. A total of 133 patients with Stanford type A AAD were included. During hospitalization, death occurred in 19 (14.3%) patients. The average hospitalization period was 12.2 days. The plasma D-dimer level of the deceased group was significantly higher than that of the survival group (14.7 ± 8.1 vs. 9.0 ± 7.2 μg/ml, P = 0.003). The in-hospital mortality was significantly higher in patients with plasma D-dimer level of at least 20 μg/ml than in those with plasma D-dimer level less than 20 μg/ml (32.3 vs. 7.5%, log rank P < 0.001). In patients not receiving surgical treatment, the in-hospital mortality was significantly higher in patients with plasma D-dimer of at least 20 μg/ml than that in those with plasma D-dimer less than 20 μg/ml (52.4 vs. 16.7%, P = 0.007). After adjustment for age, systolic blood pressure, platelet counts, and intervals from symptom onset to hospital, a high admission D-dimer level (≥20 μg/ml) was still a powerful independent predictor of in-hospital mortality (hazard ratio 3.195, 95% confidence interval 1.110–9.196, P = 0.031). However, the predictive value of high admission D-dimer level disappeared when surgery was added to the Cox multivariate model. Our results suggest a high admission D-dimer level (≥20 μg/ml) might be a powerful predictor for increased in-hospital mortality in patients with Stanford type A AAD, and these patients may benefit more from surgical intervention.
- 19 February 2014
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 16 (3) , 207-213
Orthostatic Blood Pressure Dysregulation and Polymorphisms of β‐Adrenergic Receptor Genes in Hypertensive Patients
The genetic susceptibility to orthostatic blood pressure dysregulation remains poorly understood. The association between polymorphisms of beta‐adrenergic receptor (β‐AR) genes and orthostatic blood pressure dysregulation in hypertensive patients was investigated. Two polymorphisms ofβ1‐AR(Arg389/Gly) andβ2‐AR(Arg16/Gly) were genotyped in untreated hypertensive patients and normotensive patients. In patients with untreated hypertension, the frequency ofβ1‐ARGly389 homozygote was significantly higher in patients with orthostatic hypotension (OH) (P<.0001) and lower in patients with orthostatic hypertension (OHT) (P=.002) as compared with patients with orthostatic normotension (ONT) even afterBonferroni correction. After analysis by sex and adjustment for conventional risk factors, theβ1‐ARGly389 homozygote conferred about a 3‐fold risk ofOHand independently predicted a 6.5 mm Hg greater orthostaticSBPdecrease (GG−8.9±13 mm Hg vsCC+CG−2.4±12 mm Hg,P<.001) only in female hypertensive patients. The association ofβ2‐ARArg16/Gly withOHwas not significant after adjustment for conventional risk factors. In normotensive patients, no association was identified between these two polymorphisms andOHTorOH. These results indicated that theβ1‐ARArg389/Gly polymorphism may be associated with increased risk ofOHin female hypertensive patients.
- 19 February 2014
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 16 (3) , 207-213
Orthostatic Blood Pressure Dysregulation and Polymorphisms of β‐Adrenergic Receptor Genes in Hypertensive Patients
The genetic susceptibility to orthostatic blood pressure dysregulation remains poorly understood. The association between polymorphisms of beta‐adrenergic receptor (β‐AR) genes and orthostatic blood pressure dysregulation in hypertensive patients was investigated. Two polymorphisms ofβ1‐AR(Arg389/Gly) andβ2‐AR(Arg16/Gly) were genotyped in untreated hypertensive patients and normotensive patients. In patients with untreated hypertension, the frequency ofβ1‐ARGly389 homozygote was significantly higher in patients with orthostatic hypotension (OH) (P<.0001) and lower in patients with orthostatic hypertension (OHT) (P=.002) as compared with patients with orthostatic normotension (ONT) even afterBonferroni correction. After analysis by sex and adjustment for conventional risk factors, theβ1‐ARGly389 homozygote conferred about a 3‐fold risk ofOHand independently predicted a 6.5 mm Hg greater orthostaticSBPdecrease (GG−8.9±13 mm Hg vsCC+CG−2.4±12 mm Hg,P<.001) only in female hypertensive patients. The association ofβ2‐ARArg16/Gly withOHwas not significant after adjustment for conventional risk factors. In normotensive patients, no association was identified between these two polymorphisms andOHTorOH. These results indicated that theβ1‐ARArg389/Gly polymorphism may be associated with increased risk ofOHin female hypertensive patients.